Moderate EvidencePromising research with growing clinical support from multiple studies
Natural Remedies for Chronic Prostatitis (CP/CPPS)
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common, often frustrating condition defined by pelvic or perineal pain, urinary symptoms, and quality‑of‑life impacts lasting three months or longer. In the NIH classification, most men with long‑standing symptoms fall into Category III (CP/CPPS), where no active bacterial infection is found; a smaller subset has chronic bacterial prostatitis (Category II). Because the causes are multifactorial—ranging from pelvic‑floor muscle dysfunction and central sensitization to low‑grade inflammation and psychosocial stress—people frequently seek “natural” options to complement standard urologic care. Understanding how Western and Eastern traditions evaluate these strategies can help align choices with personal goals, such as reducing pain, improving urinary or sexual function, and enhancing day‑to‑day well‑being.
From a Western biomedical perspective, evaluation aims to exclude red flags and infection, then relieve symptoms. Urologists may use the NIH‑CPSI (a validated symptom index), urinalysis and cultures, and a phenotype framework (e.g., UPOINT) to tailor multimodal care. Conventional options include alpha‑blockers, anti‑inflammatories, short antibiotic trials if infection is suspected, pelvic‑floor physical therapy, neuropathic pain medications, and behavioral stress management. Within this framework, several “natural” or nonpharmacologic interventions are studied. Pelvic‑floor physical therapy and myofascial trigger‑point release show meaningful improvements in global response and pain in randomized trials, likely by normalizing muscle tone and reducing peripheral nociception. Among nutraceuticals, quercetin—a flavonoid with antioxidant and mast‑cell–modulating properties—improved NIH‑CPSI scores in a small placebo‑controlled trial, with some replication in combination products. Rye‑grass pollen extracts (e.g., standardized Cernilton‑type products) have reduced pain and total NIH‑CPSI scores in several RCT
mens-health
Updated March 20, 2026